<DOC>
	<DOCNO>NCT00702793</DOCNO>
	<brief_summary>This 15 week trial determine ( 1 ) safety tolerability varenicline use smoke cessation/reduction individual schizophrenia ; ( 2 ) treatment varenicline affect symptom schizophrenia .</brief_summary>
	<brief_title>Safety Tolerability Varenicline Schizophrenia ( SATOVA )</brief_title>
	<detailed_description>Researchers look recruit total 50 subject Riverview Forensic Psychiatric Hospitals would like reduce quit smoking cigarette . This open label pilot study gather information regard safety tolerability varenicline subject diagnose schizophrenia schizoaffective disorder . Consenting subject prescribe varenicline follow : varenicline 0.5 mg/d day 1 3 , 0.5 mg twice daily day 4 7 , 1 mg twice daily week 12 . The research team meet subject week twelve week subject interview ask complete questionnaire his/her psychiatric symptom , tobacco use nicotine dependence . The measure use include FTND , PANSS , CGI-I , CGI-S , ESRS , UKU , BARS , WSWS , QSU-brief , mCEQ , OAS-M . The CGI-SS also complete throughout study well weekly three week follow completion study ( Post-Study follow-up visit 1-3 ) .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Inpatients diagnosis schizophrenia schizoaffective disorder Individuals age 19 65 year age Individuals smoke 10 cigarette/day previous year , period smoking abstinence longer 3 month past year Individuals expect discharged hospital within 4 month . Clinically significant allergic reaction study medication Clinically significant abnormality screen laboratory value Subjects significant risk selfharm Previous treatment varenicline Women pregnant , breastfeeding , childbearing potential use adequate contraception Men use adequate contraception Use medication might interfere study medication evaluation Nicotine replacement Nortriptyline Clonidine</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective</keyword>
	<keyword>psychosis</keyword>
	<keyword>varenicline</keyword>
	<keyword>champix</keyword>
	<keyword>chantix</keyword>
	<keyword>nicotine dependence</keyword>
</DOC>